The Standard-Journal
September 24, 2024
On November 5th, Pennsylvania voters will elect a US Senator to represent our interests in Washington for the next six years. Our choice: incumbent Democratic Senator Bob Casey, Jr. or Republican challenger David McCormick (who lost in the 2022 primary election).
Your decision and your vote could have a major impact on your life and health.
Currently, the 2022 Inflation Reduction Act (IRA) lets Medicare negotiate drug prices with manufacturers and prevents drug companies from increasing these prices beyond inflation. It caps out-of-pocket prescription drug costs for seniors at $2,000 per year. It limits the cost of insulin to $35.00 per month for Medicare recipients. The IRA also extends Affordable Care Act (ACA) marketplace subsidies through 2025, saving seniors an average of $800 per year.
McCormick is against all that. He supports Republican proposals to repeal Medicare’s ability to negotiate drug prices. He supports proposals to make Medicare Advantage the default enrollment option “for people who are newly eligible for Medicare,” which would gradually phase out traditional Medicare. He supports former president Donald Trump’s plan to replace the ACA with his “concept for a plan.”
Senator Casey has experience in this area. He serves on the Committee on Health, Education, Labor, and Pensions and on the Committee on Finance. He has vowed to maintain and improve the current Social Security and Medicare programs. He favors protecting and expanding the ACA to provide health care for all Pennsylvanians.
If you are one of the 329,000 Pennsylvania residents on Social Security or the 2.8 million on Medicare, the choice is obvious. Re-elect Senator Bob Casey, Jr. For your health. For our health.
David B. Kyle
New Columbia